BioLine Rx News

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 17 17:15 ET

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 6 07:18 ET

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 17 07:14 ET

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 10 07:27 ET

BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 1 10:36 ET

BioLine Rx | 424B5: Prospectus

Apr 1 10:36 ET

BioLine Rx | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

Mar 26 17:00 ET

BioLine Rx | 20-F: Registration statement / Annual report / Transition report

Mar 26 08:04 ET

BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 26 07:09 ET

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 4 07:50 ET

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 28 07:12 ET

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 16 07:11 ET

BioLine Rx | EFFECT: Others

Jan 8 00:00 ET

BioLine Rx | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 29, 2023 00:00 ET

BioLine Rx | F-3: Registration statement for specified transactions by certain foreign private issuers

Dec 29, 2023 00:00 ET

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 21, 2023 07:05 ET

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 12, 2023 07:07 ET

BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 20, 2023 07:03 ET

BioLine Rx | SC 13D: Statement of acquisition of beneficial ownership by individuals

Oct 26, 2023 14:18 ET

BioLine Rx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 12, 2023 07:14 ET